Home > Annual Financials > SOLARA ACTIVE PHARMA SCIENCE

SOLARA ACTIVE PHARMA SCIENCE Financial Statement Analysis
[BOM: 541540|NSE : SOLARA]

The Revenues of SOLARA ACTIVE PHARMA SCIENCE have increased by 13.83% YoY .
The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SOLARA ACTIVE PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 541540|NSE : SOLARA]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹1,444 Cr₹1,268 Cr₹1,617 Cr₹1,322 Cr₹1,409 Cr
Expenses ₹1,310 Cr₹1,188 Cr₹1,231 Cr₹1,062 Cr₹1,197 Cr
Operating Profit (Excl OI) ₹134 Cr₹80 Cr₹386 Cr₹259 Cr₹212 Cr
Other Income ₹23 Cr₹20 Cr₹29 Cr₹28 Cr₹12 Cr
Interest ₹90 Cr₹75 Cr₹84 Cr₹78 Cr₹82 Cr
Depreciation ₹111 Cr₹112 Cr₹109 Cr₹94 Cr₹84 Cr
Profit Before Tax ₹-45 Cr₹-91 Cr₹222 Cr₹115 Cr₹58 Cr
Profit After Tax ₹-22 Cr₹-58 Cr₹221 Cr₹115 Cr₹59 Cr
Consolidated Net Profit ₹-22 Cr₹-58 Cr₹221 Cr₹115 Cr₹60 Cr
Earnings Per Share (Rs)₹-6.16₹-16.15₹61.62₹42.69₹23.09
PAT Margin (%)-1.54-4.6013.698.664.22
ROE(%)-1.47-3.7517.2312.487.36
ROCE(%)1.79-0.6715.3411.739.70
Total Debt/Equity(x)0.670.670.380.720.63

Key Financials

Market Cap : ₹ 1,340.8 Cr
Revenue (TTM) : ₹ 1,406.9 Cr
Net Profit(TTM) : ₹ -307.8 Cr
EPS (TTM) : ₹ -85.5
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
SOLARA ACTIVE PHARMA SCIENCE 0.3% -24.2% 5.4%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%


SOLARA ACTIVE PHARMA SCIENCE Revenues
[BOM: 541540|NSE : SOLARA]

Y-o-Y

13.83 %

5 Yr CAGR

0.62 %

Years Revenues % Change
Mar2023 ₹1,444 Cr
13.83
Mar2022 ₹1,268 Cr
-21.56
Mar2021 ₹1,617 Cr
22.33
Mar2020 ₹1,322 Cr
-6.16
Mar2019 ₹1,409 Cr -


SOLARA ACTIVE PHARMA SCIENCE Operating Profit
[BOM: 541540|NSE : SOLARA]

Y-o-Y

67.41 %

5 Yr CAGR

-10.81 %

Years Operating Profit % Change
Mar2023 ₹134 Cr
67.41
Mar2022 ₹80 Cr
-79.28
Mar2021 ₹386 Cr
48.73
Mar2020 ₹259 Cr
22.64
Mar2019 ₹212 Cr -

Operating Margins
Y-o-Y

46.91 %

5 Yr CAGR

-11.37 %

Years Operating Margin% % Change
Mar2023 9.27%
46.91
Mar2022 6.31%
-73.57
Mar2021 23.87%
21.60
Mar2020 19.63%
30.69
Mar2019 15.02% -

SOLARA ACTIVE PHARMA SCIENCE Profit After Tax
[BOM: 541540|NSE : SOLARA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2023 ₹-22 Cr
Negative
Mar2022 ₹-58 Cr
Negative
Mar2021 ₹221 Cr
93.18
Mar2020 ₹115 Cr
92.59
Mar2019 ₹60 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -1.54 %
Negative
Mar2022 -4.6 %
Negative
Mar2021 13.69 %
58.08
Mar2020 8.66 %
105.21
Mar2019 4.22 % -

SOLARA ACTIVE PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 541540|NSE : SOLARA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-6.16
Negative
Mar2022 ₹-16
Negative
Mar2021 ₹62
44.34
Mar2020 ₹43
84.89
Mar2019 ₹23 -

SOLARA ACTIVE PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 541540|NSE : SOLARA]

Y-o-Y

Positive

5 Yr CAGR

-34.46 %

Years ROCE % Change
Mar2023 1.79%
Positive
Mar2022 -0.67%
Negative
Mar2021 15.34%
30.78
Mar2020 11.73%
20.93
Mar2019 9.7% -

SOLARA ACTIVE PHARMA SCIENCE Share Price vs Sensex

Current Share Price : ₹372.5
Current MarketCap: ₹ 1,340.8 Cr
Updated EOD on :Mar 28,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCE

0.3%

-24.2%

5.4%

SENSEX

-0.4%

-0.9%

25.8%

SOLARA ACTIVE PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 1.9% -4.4% 61.2%
S&P BSE SMALL CAP 1.8% -6.7% 58.8%
S&P BSE HEALTHCARE 1% -3.2% 60.6%
S&P BSE ALLCAP 0.8% -1.8% 40.5%
No NSE index found

You may also like the below Video Courses


FAQ about SOLARA ACTIVE PHARMA SCIENCE Financials


How the annual revenues of SOLARA ACTIVE PHARMA SCIENCE have changed ?

The Revenues of SOLARA ACTIVE PHARMA SCIENCE have increased by 13.83% YoY .

How the Earnings per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE have changed?

The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE has decreased by Negative YoY .